# Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With...
**FDA Update**

**2023-10-22 23:30**

**https://www.ainvest.com/news/celltrion-usa-announces-u-s-fda-approval-of-zymfentra-infliximab-dyyb-first-and-only-subcutaneous-infliximab-for-treatment-of-people-with-inflammatory-bowel-disease-231010002a5103ce296c1ee0/**

Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease